Medical Properties Trust Inc
NYSE: MPW · REAL ESTATE · REIT - HEALTHCARE FACILITIES
Updated 2026-01-30
Medical Properties Trust Inc (MPW) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for MPW.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
MPW historical valuation range
Where current P/E sits in MPW's own 5Y range.
MPW intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Standard discounted cash flow models produce unreliable output for unprofitable or near-breakeven companies. Revenue-based multiples such as P/S and EV/Sales, combined with the historical valuation position above, give a more reliable read for this stock.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
MPW valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
P/S Ratio — History
Current: 2.99x
Is MPW overvalued in 2026?
Medical Properties Trust Inc (MPW) currently trades at $5.02 per share with a market capitalization of $3,019,530,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 51/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
MPW currently has no meaningful P/E ratio, which typically signals that the company is unprofitable, near breakeven, or emerging from a loss-making period. With a P/S ratio of 3.0x, the market is valuing the company primarily on its revenue rather than its earnings.
A standard DCF model does not produce reliable output for MPW under current conditions. For unprofitable or near-breakeven companies, revenue-based multiples such as EV/Sales and historical P/S percentile are more informative than intrinsic value calculations.
The Piotroski F-Score of 5/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: MPW trades at a fair valuation on our framework, with a Smart Value Score of 51/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is MPW overvalued?
MPW scores 51/100 on our Smart Value Score (Grade C), a mixed overall profile. A standard DCF is unreliable here given the profitability profile, so valuation leans on revenue-based measures like EV/Sales and the P/S percentile below.
What is MPW's fair value?
A standard DCF is unreliable for MPW given its current profitability profile. Revenue-based approaches like EV/Sales or the historical P/S percentile are more informative for this stock.
What P/E ratio does MPW trade at?
MPW does not have a meaningful P/E right now, usually a sign of unprofitability or an earnings transition. For unprofitable growth names, price-to-sales is the more useful gauge.
Is MPW a buy based on valuation?
Our Smart Value rating for MPW is Hold, from a Smart Value Score of 51/100 that blends growth, quality, and valuation. The profile is balanced and best suited to investors who already have a thesis. This is research to inform your decision, not personalized financial advice.
How does MPW's valuation compare to its history?
There is not enough historical valuation data yet for a confident percentile read on MPW.
What is MPW's Smart Value Score?
MPW's Smart Value Score is 51/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.